UnitedHealth Group Incorporated (UNH)
Latest news, insights and market data
Market Data
AI Insights
UnitedHealth Group has divested certain operations to the Pennant Group as part of an antitrust settlement with the Justice Department. This move reflects ongoing adjustments in their business strategy and regulatory compliance. Keep an eye on how this affects their future operational focus and market positioning.
Latest News
Title | Published |
---|---|
What Does Wall Street Think About UnitedHealth Group (UNH)? What Does Wall Street Think About UnitedHealth Group (UNH)? | about 4 hours ago |
What Does Wall Street Think About UnitedHealth Group (UNH)? UnitedHealth Group Incorporated (NYSE:UNH) is one of the best medical stocks to buy now. In a report released on September 18, Ryan Langston from TD Cowen maintained a Hold rating on UnitedHealth Group Incorporated (NYSE:UNH) and set a price target of $275.00. However, UBS reiterated a Buy rating on UnitedHealth Group Incorporated (NYSE:UNH) on September […] | about 4 hours ago |
2 Healthcare Stocks to Research Further and 1 Facing Challenges 2 Healthcare Stocks to Research Further and 1 Facing Challenges | about 10 hours ago |
2 Healthcare Stocks to Research Further and 1 Facing Challenges Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This has capped returns as the industry’s six-month gain of 6.5% has lagged the S&P 500’s 24.7% climb. | about 10 hours ago |
UnitedHealth Group (UNH) Rises Higher Than Market: Key Facts UnitedHealth Group (UNH) Rises Higher Than Market: Key Facts | about 17 hours ago |
UnitedHealth Group (UNH) Rises Higher Than Market: Key Facts In the closing of the recent trading day, UnitedHealth Group (UNH) stood at $353.72, denoting a +1.56% move from the preceding trading day. | about 17 hours ago |
UPDATE — Pennant Completes Purchase of Tennessee, Georgia and Alabama Operations from UnitedHealth Group and Amedisys UPDATE — Pennant Completes Purchase of Tennessee, Georgia and Alabama Operations from UnitedHealth Group and Amedisys | about 20 hours ago |
What Does Wall Street Think About UnitedHealth Group (UNH)?
What Does Wall Street Think About UnitedHealth Group (UNH)?
What Does Wall Street Think About UnitedHealth Group (UNH)?
UnitedHealth Group Incorporated (NYSE:UNH) is one of the best medical stocks to buy now. In a report released on September 18, Ryan Langston from TD Cowen maintained a Hold rating on UnitedHealth Group Incorporated (NYSE:UNH) and set a price target of $275.00. However, UBS reiterated a Buy rating on UnitedHealth Group Incorporated (NYSE:UNH) on September […]
2 Healthcare Stocks to Research Further and 1 Facing Challenges
2 Healthcare Stocks to Research Further and 1 Facing Challenges
2 Healthcare Stocks to Research Further and 1 Facing Challenges
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This has capped returns as the industry’s six-month gain of 6.5% has lagged the S&P 500’s 24.7% climb.
UnitedHealth Group (UNH) Rises Higher Than Market: Key Facts
UnitedHealth Group (UNH) Rises Higher Than Market: Key Facts
UnitedHealth Group (UNH) Rises Higher Than Market: Key Facts
In the closing of the recent trading day, UnitedHealth Group (UNH) stood at $353.72, denoting a +1.56% move from the preceding trading day.
UPDATE — Pennant Completes Purchase of Tennessee, Georgia and Alabama Operations from UnitedHealth Group and Amedisys
UPDATE — Pennant Completes Purchase of Tennessee, Georgia and Alabama Operations from UnitedHealth Group and Amedisys